Chemotherapy-induced peripheral neuropathy
Conditions
Interventions
Trial group:2HZ Electroacupuncture frequency
Control group:Mecobalamin tablets by mouth
Sponsors
The Third Affiliated Hospital of Zhejiang Chinese Medicine University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.The people whose pathological result is malignant tumor,with numbness of limbs after accpeting the chemotherapy of platinum, taxol, vinblastine or other tablets; 2.18=6 months; 3.The score of Karnofsky>=70; 4.There are no previous diseases or conditions that can lead to peripheral neuropathy and similar symptoms, such as nervous system diseases and diabetes; 5.The people who have no intellectual and mental disorders, normal language expression ability, have the ability to judge their own numbness and other symptoms and general conditions, and can cooperate to evaluate symptoms and quality of life; 6.The people without strict center of gravity, liver, kidney, hematopoietic system diseases and other factors affecting the effect evaluation;7.The people who sign informed consent and voluntarily participate in this study
Exclusion criteria
Exclusion criteria: 1.The people with obvious impairment of heart, liver, kidney or hematopoietic function, or psychosis, pregnant women or lactating women; 2.The people with a history of skin allergic diseases; 3.The people with hand and foot injuries, ulcers or infections; 4.The people who are participating in other drug trials; 5.The researcher consider that it is not appropriate to participate in this experiment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical version of comprehensive neuropathy assessment tool;Neuroelectromyography; | — |
Countries
China
Contacts
Public ContactChen Weiji
Outcome results
None listed